Zebrafish embryo as a replacement model for initial biocompatibility studies of biomaterials and drug delivery systems. (December 2019)
- Record Type:
- Journal Article
- Title:
- Zebrafish embryo as a replacement model for initial biocompatibility studies of biomaterials and drug delivery systems. (December 2019)
- Main Title:
- Zebrafish embryo as a replacement model for initial biocompatibility studies of biomaterials and drug delivery systems
- Authors:
- Rothenbücher, Theresa S.P.
Ledin, Johan
Gibbs, David
Engqvist, Håkan
Persson, Cecilia
Hulsart-Billström, Gry - Abstract:
- Abstract: The development of new biomaterials and drug delivery systems necessitates animal experimentation to demonstrate biocompatibility and therapeutic efficacy. Reduction and replacement of the requirement to conduct experiment using full-grown animals has been achieved through utilising zebrafish embryos, a promising bridge model between in vitro and in vivo research. In this review, we consider how zebrafish embryos have been utilised to test both the biocompatibility of materials developed to interact with the human body and drug release studies. Furthermore, we outline the advantages and limitations of this model and review legal and ethical issues. We anticipate increasing application of the zebrafish model for biomaterial evaluation in the near future. Statement of significance: This review aims to evaluate the potential application and suitability of the zebrafish model in the development of biomaterials and drug delivery systems. It creates scientific impact and interest because replacement models are desirable to the society and the scientific community. The continuous development of biomaterials calls for the need to provide solutions for biological testing. This review covers the topic of how the FET model can be applied to evaluate biocompatibility. Further, it explores the zebrafish from the wild-type to the mutant form, followed by a discussion about the ethical considerations and concerns when using the FET model. Graphical abstract: Image, graphicalAbstract: The development of new biomaterials and drug delivery systems necessitates animal experimentation to demonstrate biocompatibility and therapeutic efficacy. Reduction and replacement of the requirement to conduct experiment using full-grown animals has been achieved through utilising zebrafish embryos, a promising bridge model between in vitro and in vivo research. In this review, we consider how zebrafish embryos have been utilised to test both the biocompatibility of materials developed to interact with the human body and drug release studies. Furthermore, we outline the advantages and limitations of this model and review legal and ethical issues. We anticipate increasing application of the zebrafish model for biomaterial evaluation in the near future. Statement of significance: This review aims to evaluate the potential application and suitability of the zebrafish model in the development of biomaterials and drug delivery systems. It creates scientific impact and interest because replacement models are desirable to the society and the scientific community. The continuous development of biomaterials calls for the need to provide solutions for biological testing. This review covers the topic of how the FET model can be applied to evaluate biocompatibility. Further, it explores the zebrafish from the wild-type to the mutant form, followed by a discussion about the ethical considerations and concerns when using the FET model. Graphical abstract: Image, graphical abstract … (more)
- Is Part Of:
- Acta biomaterialia. Volume 100(2019)
- Journal:
- Acta biomaterialia
- Issue:
- Volume 100(2019)
- Issue Display:
- Volume 100, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 100
- Issue:
- 2019
- Issue Sort Value:
- 2019-0100-2019-0000
- Page Start:
- 235
- Page End:
- 243
- Publication Date:
- 2019-12
- Subjects:
- Zebrafish -- High-throughput -- FET test -- Fish embryo toxicity -- 3Rs
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17427061 ↗
http://www.elsevier.com/wps/find/journaldescription.cws%5Fhome/702994/description ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.actbio.2019.09.038 ↗
- Languages:
- English
- ISSNs:
- 1742-7061
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0602.900500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25898.xml